Stanley Ng, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2299 Bacon St Ste 7, Concord, CA 94520 Phone: 925-676-6500 |
Dr. Taraneh Mostaghasi, M. D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3108 Willow Pass Rd, Concord, CA 94519 Phone: 551-804-7891 |
Dr. Kelly D Beatty, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2165 East Street, Concord, CA 94520 Phone: 925-827-9195 Fax: 925-827-9278 |
Dr. Candice K Smith, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1699 Baywood Dr, Concord, CA 94521 Phone: 925-603-3432 |
Dr. Jennifer L Burgham, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2165 East Street, Concord, CA 94520 Phone: 925-827-9195 Fax: 925-827-9278 |
Dr. Jennifer F Holden, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2165 East Street, Concord, CA 94520 Phone: 925-827-9195 Fax: 925-827-9278 |
Robert Amaru Elliott, Pediatrics Medicare: Medicare Enrolled Practice Location: 2000 Sierra Rd, Concord, CA 94518 Phone: 925-363-2000 Fax: 925-363-2006 |
News Archive
New landmark data (the STAR Study), revealed today from the European Association of Urology in Istanbul, Turkey, show that patients suffering from Overactive Bladder (OAB) syndrome will see considerably better improvements in their symptoms when being treated with the new antimuscarinic drug solifenacin, than on tolterodine ER - an antimuscarinic drug that is widely used.
Still, reports on the ground vary - with some states offering positive news, while others still are limping along. Here is a sampling of coverage from Kentucky, Minnesota, Illinois, Colorado, Hawaii, Oregon and Massachusetts.
G8 development ministers "agreed to a set of guiding principles [for Canada's G8 maternal and child health initiative] that leaves flexibility for countries to 'build their basket of initiatives,'" Bev Oda, the Canadian minister for international cooperation, said at a closing news conference on Wednesday, the Toronto Star reports.
House Republicans issued a report Wednesday and plan to hold a hearing Friday to investigate AARP's support for the health law as well as the organization's business interests.
Exelixis, Inc. today reported long-term results in a cohort of 37 medullary thyroid cancer (MTC) patients who participated in the phase 1 study of XL184. Dr. Razelle Kurzrock from the MD Anderson Cancer Center in Houston, TX will present the data in a Clinical Science Symposium (Abstract #5502) on Monday, June 7 at 10:15 AM at the 2010 Annual Meeting of the American Society of Clinical Oncology in Chicago.
› Verified 6 days ago